Surrozen, Inc. (NASDAQ:SRZN – Get Free Report) CFO Charles O. Williams sold 1,181 shares of the business’s stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $17.37, for a total value of $20,513.97. Following the transaction, the chief financial officer now owns 8,982 shares in the company, valued at $156,017.34. This represents a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Surrozen Trading Down 1.1 %
SRZN stock opened at $12.81 on Thursday. Surrozen, Inc. has a 1-year low of $6.00 and a 1-year high of $18.17. The business’s 50 day moving average is $11.11 and its 200-day moving average is $9.97.
Surrozen (NASDAQ:SRZN – Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The company reported ($0.44) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.77) by $2.33. The company had revenue of $10.00 million during the quarter. On average, analysts forecast that Surrozen, Inc. will post -7.16 earnings per share for the current year.
Institutional Investors Weigh In On Surrozen
Analysts Set New Price Targets
Separately, Guggenheim upgraded shares of Surrozen from a “neutral” rating to a “buy” rating and set a $45.00 target price on the stock in a research report on Friday, January 3rd.
View Our Latest Analysis on SRZN
About Surrozen
Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.
See Also
- Five stocks we like better than Surrozen
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- What is the MACD Indicator and How to Use it in Your Trading
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Surrozen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surrozen and related companies with MarketBeat.com's FREE daily email newsletter.